Stock Taper
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
4 CALLS ON FILE
DARE
— Dare Bioscience, Inc.
NASDAQ
FULL STOCK PAGE →
Q1 2026 Earnings Call Summary
MAY 14, 2026
REVENUE
$152455
-85.1%
NET MARGIN
-1967.7%
-1826.9 PTS
EPS
-$0.21
-111.3%
FREE CASH FLOW
-$5.5M
-546.1%
No summary has been written for this call yet.
← NEWER CALL
CALL 2 OF 4
OLDER CALL →